Pharmaceuticals

Global Psychedelic Drugs Market 2025–2029: Competitive Insights and Opportunities

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Psychedelic Drugs Industry In 2025?

The psychedelic drugs market size has experienced significant expansion in recent years. Projections indicate a rise from $5.56 billion in 2024 to $6.33 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.9%. This historical growth can be linked to factors such as a shifting regulatory landscape, heightened mental health awareness, and evolving public perception.

The psychedelic drugs market size is projected to undergo significant expansion in the upcoming years. It is anticipated to grow to “$11.68 billion in 2029, achieving a compound annual growth rate (CAGR) of 16.5%. This growth throughout the forecast period can be primarily ascribed to advancements in drug development, the broadening of therapeutic applications, increasing acceptance within the medical community, shifts in public policy, and the response to the mental health crisis. Noteworthy trends expected during this forecast timeframe involve a strong focus on education and public awareness, evolving legal and regulatory developments, the diversification of psychedelic compounds, and the adoption of patient-centric treatment approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

What Are The Key Drivers Of Growth In The Psychedelic Drugs Market?

The rising incidence of mental illnesses is projected to propel the growth of the psychedelic drugs market. Mental illnesses are defined as health conditions involving alterations in emotion, thinking, or behavior, and they include conditions such as distress and post-traumatic stress disorder. Psychedelic drugs are utilized for treating depression and post-traumatic stress disorder, with their consistent application leading to a reduction in mental illnesses. For instance, in November 2022, the National Centre for Social Research, a UK-based social research institute, reported that the percentage of 17- to 19-year-olds with a suspected mental disorder increased from 17.4% in 2021 to 25.7% in 2022. Consequently, the growing number of mental illness cases is a key factor driving the expansion of the psychedelic drugs market.

What Are The Different Segment Classifications Within The Psychedelic Drugs Market?

The psychedelic drugs market covered in this report is segmented –

1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

2) By Disease Indication: Depression, PTSD

3) By Origin: Natural, Synthetic

4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders

5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters

2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable

3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid

4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules

5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures

What Key Innovation Trends Are Fueling Advancements In The Psychedelic Drugs Market?

Leading firms within the psychedelic drugs sector are concentrating on cutting-edge offerings, including ketamine, with the aim of boosting therapeutic results for mental health issues, increasing patient access to care, and investigating fresh uses for psychedelic compounds in conditions such as depression, anxiety, PTSD, and substance use disorders. Ketamine serves as a drug utilized for anesthesia and pain relief, recognized for its dissociative characteristics. Furthermore, its swift antidepressant qualities are under examination for managing ailments such as severe depression and PTSD. An example of this is seen in March 2022, when Husch Blackwell, a US-based traditional company, established the Psychedelics and Emerging Therapies Practice Group. This group aims to support innovators through the research, development, and market introduction phases of new psychedelic-based treatments. It consists of a diverse legal team skilled in maneuvering through the intricate legal environment associated with these compounds, frequently designated as Schedule I controlled substances under U.S. federal law. Such a classification introduces considerable regulatory hurdles that may impede advancements in research and development.

Which Major Industry Participants Are Leading The Psychedelic Drugs Market Growth?

Major companies operating in the psychedelic drugs market include Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Which Region Is Projected To Lead The Psychedelic Drugs Market During The Forecast Period?

North America was the largest region in the psychedelic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Psychedelic Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp

Browse Through More Reports Similar to the Global Psychedelic Drugs Market 2025, By The Business Research Company

Cardiovascular Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795